CLINICAL_TRIALS
trial_result
· 2024-02-16
Clinical Trial Update: A Study Testing How BI 655130 Works in Patients With Fistulizing Crohn's Disease [Phase 2]
Summary
This Phase 2 trial of BI 655130 for fistulizing Crohn's disease has completed, with results posted on February 16, 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Crohn Disease | Phase 2 | Status: COMPLETED | Results posted: 2024-02-16